Anticoagulation strategies in patients with extracorporeal membrane oxygenation: a network meta ‐analysis and systematic review
ConclusionsCompared with UFH and Arg, Biv reduces the risk of thrombosis and appears to be a better choice for patients requiring ECMO. NM was associated with a reduced risk of in-hospital mortality.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Jiale Chen,
Guoquan Chen,
Wenyi Zhao,
Wenxing Peng Tags: REVIEW Source Type: research
More News: Angiomax | Bleeding | Drugs & Pharmacology | Pulmonary Thromboembolism | Science | Study | Thrombosis